Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zyprexa Adhera in schizophrenia or schizoaffective disorder
NCT00088465Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2004
- Primary completion
- Dec 2010
- Countries
- 25
01
Overview
A Phase 3 trial of Zyprexa Adhera in schizophrenia, schizoaffective disorder, sponsored by Eli Lilly and Company. Started Aug 2004; status: completed.
02
Drugs
Zyprexa Adhera
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00088465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00088465.